Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp Block for Analgesia in Craniotomy
NCT06720285Phase 1Completed
- Sponsor
- Universitas Airlangga
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Universitas Airlangga. Primary endpoint: Total opioid consumption. Started Oct 2023; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06720285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06720285.